321 related articles for article (PubMed ID: 9657561)
61. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma.
Mattes J; Storm van's Gravesande K; Reining U; Alving K; Ihorst G; Henschen M; Kuehr J
Eur Respir J; 1999 Jun; 13(6):1391-5. PubMed ID: 10445617
[TBL] [Abstract][Full Text] [Related]
62. Salmeterol reduces the need for inhaled corticosteroid in steroid-dependent asthmatics.
Nielsen LP; Pedersen B; Faurschou P; Madsen F; Wilcke JT; Dahl R
Respir Med; 1999 Dec; 93(12):863-8. PubMed ID: 10653047
[TBL] [Abstract][Full Text] [Related]
63. Granulocyte proteins in serum in childhood asthma: relation to spirometry and therapy.
Scher H; Berman D; Weinberg EG; Schinkel M; Peper B; Chalton DO; Potter PC
Clin Exp Allergy; 1996 Oct; 26(10):1131-41. PubMed ID: 8911698
[TBL] [Abstract][Full Text] [Related]
64. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
Fowler SJ; Currie GP; Lipworth BJ
J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
[TBL] [Abstract][Full Text] [Related]
65. The inflammatory marker serum eosinophil cationic protein (ECP) compared with PEF as a tool to decide inhaled corticosteroid dose in asthmatic patients.
Löwhagen O; Wever AM; Lusuardi M; Moscato G; De Backer WA; Gandola L; Donner CF; Ahlstedt S; Larsson L; Holgate ST
Respir Med; 2002 Feb; 96(2):95-101. PubMed ID: 11862965
[TBL] [Abstract][Full Text] [Related]
66. Efficacy and safety of once or twice daily inhalation of extrafine HFA beclomethasone dipropionate in patients with mild to moderate asthma.
Gillissen A; Richter A; Oster H; Criée CP
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):233-41. PubMed ID: 18204133
[TBL] [Abstract][Full Text] [Related]
67. Exhaled nitric oxide and sputum eosinophil markers of inflammation in asthmatic children.
Piacentini GL; Bodini A; Costella S; Vicentini L; Mazzi P; Sperandio S; Boner AL
Eur Respir J; 1999 Jun; 13(6):1386-90. PubMed ID: 10445616
[TBL] [Abstract][Full Text] [Related]
68. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements.
Pizzichini E; Pizzichini MM; Efthimiadis A; Evans S; Morris MM; Squillace D; Gleich GJ; Dolovich J; Hargreave FE
Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):308-17. PubMed ID: 8756799
[TBL] [Abstract][Full Text] [Related]
69. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.
Pauwels RA; Yernault JC; Demedts MG; Geusens P
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):827-32. PubMed ID: 9517598
[TBL] [Abstract][Full Text] [Related]
70. Hypodense eosinophil number relates to clinical severity, airway hyperresponsiveness and response to inhaled corticosteroids in asthmatic subjects.
Kuo HP; Yu TR; Yu CT
Eur Respir J; 1994 Aug; 7(8):1452-9. PubMed ID: 7957830
[TBL] [Abstract][Full Text] [Related]
71. The effect of high-dose inhaled beclomethasone dipropionate in patients with stable COPD.
Nishimura K; Koyama H; Ikeda A; Tsukino M; Hajiro T; Mishima M; Izumi T
Chest; 1999 Jan; 115(1):31-7. PubMed ID: 9925060
[TBL] [Abstract][Full Text] [Related]
72. Mild exacerbations and eosinophilic inflammation in patients with stable, well-controlled asthma after 1 year of follow-up.
Belda J; Giner J; Casan P; Sanchis J
Chest; 2001 Apr; 119(4):1011-7. PubMed ID: 11296162
[TBL] [Abstract][Full Text] [Related]
73. Salmeterol added to inhaled corticosteroid therapy is superior to doubling the dose of inhaled corticosteroids: a randomized clinical trial.
Kelsen SG; Church NL; Gillman SA; Lanier BQ; Emmett AH; Rickard KA; Anderson WH
J Asthma; 1999 Dec; 36(8):703-15. PubMed ID: 10609625
[TBL] [Abstract][Full Text] [Related]
74. Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years.
Tattersfield AE; Town GI; Johnell O; Picado C; Aubier M; Braillon P; Karlström R
Thorax; 2001 Apr; 56(4):272-8. PubMed ID: 11254817
[TBL] [Abstract][Full Text] [Related]
75. A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate.
Fairfax A; Hall I; Spelman R
Ann Allergy Asthma Immunol; 2001 May; 86(5):575-82. PubMed ID: 11379810
[TBL] [Abstract][Full Text] [Related]
76. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.
Diamant Z; Grootendorst DC; Veselic-Charvat M; Timmers MC; De Smet M; Leff JA; Seidenberg BC; Zwinderman AH; Peszek I; Sterk PJ
Clin Exp Allergy; 1999 Jan; 29(1):42-51. PubMed ID: 10051701
[TBL] [Abstract][Full Text] [Related]
77. [Duration of the effect of inhaled corticosteroids on lung function and sensitivity of the respiratory tract in patients with bronchial asthma].
Magnussen H; Willenbrock U; Jörres R
Med Klin (Munich); 1995 Apr; 90(4):214-9. PubMed ID: 7776933
[TBL] [Abstract][Full Text] [Related]
78. Lung function and asthma control with beclomethasone and formoterol in a single inhaler.
Huchon G; Magnussen H; Chuchalin A; Dymek L; Gonod FB; Bousquet J
Respir Med; 2009 Jan; 103(1):41-9. PubMed ID: 18977646
[TBL] [Abstract][Full Text] [Related]
79. Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects.
Dente FL; Bancalari L; Bacci E; Bartoli ML; Carnevali S; Cianchetti S; Di Franco A; Giannini D; Vagaggini B; Testi R; Paggiaro PL
Thorax; 1999 Jul; 54(7):622-4. PubMed ID: 10377209
[TBL] [Abstract][Full Text] [Related]
80. Real life clinical study design supporting the effectiveness of extra-fine inhaled beclomethasone/formoterol at the level of small airways of asthmatics.
Popov TA; Petrova D; Kralimarkova TZ; Ivanov Y; Popova T; Peneva M; Odzhakova T; Ilieva Y; Yakovliev P; Lazarova T; Georgiev O; Hodzhev V; Hodzheva E; Staevska MT; Dimitrov VD
Pulm Pharmacol Ther; 2013 Dec; 26(6):624-9. PubMed ID: 23769863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
